TrialBMC gastroenterology2020

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial.

Jieting Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.